NASDAQ: HALO       Halozyme Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
23.54   -0.06 (0.25%)  23.23 - 24.43  137,997


Avg Volume (4 weeks):1,564,400
4 Weeks Range:22.50 - 25.68
4 Weeks Price Volatility (%):
52 Weeks Range:12.71 - 25.68
52 Weeks Price Volatility (%):
Average Price Target: 6.50
Price Target Upside/Downside: -17.04


No recent Headlines for this stock.

Business Background

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3883  1820  371  2881 

Top 10 Active Counters
 CIDM 3.79+2.48 
 VISL 0.972+0.547 
 AAL 15.05+3.20 
 GNUS 4.74-3.19 
 XSPA 1.74+0.66 
 NIO 6.085+0.485 
 AVP 5.60-0.05 
 DAL 32.34+3.87 
 UAL 39.09+5.44 
 SAVE 21.60+4.29 
Partners & Brokers